Compare

Johnson & Johnson vs Merck

Johnson & Johnson (JNJ) and Merck (MRK) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Johnson & Johnson JNJNYSE · PharmaceuticalsMerck MRKNYSE · Pharmaceuticals
Insider records, last 12 months280179
Congress trades, last 12 months259
Fund positions reported, last 12 months587451
Federal contract awards, last 12 months1611
Open-market purchases by insiders since 20062530
Open-market sales by insiders since 2006440391
Last open-market purchase by an insiderDec 1, 2025Feb 7, 2025
Next resultsOct 13, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Johnson & Johnson or Merck?

Since 2006, Merck insiders reported 30 open-market purchases against 25 for Johnson & Johnson, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade JNJ or MRK?

In the last 12 months, members of Congress disclosed 25 trades in Johnson & Johnson (JNJ) and 9 in Merck (MRK), each reported as a value range on a periodic transaction report.

When did insiders last buy JNJ and MRK?

Johnson & Johnson: Dec 1, 2025. Merck: Feb 7, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Johnson & Johnson free$9.99 a month, cancel anytime

Johnson & Johnson pageMerck pageRare insider trades this weekAll comparisons

https://oqro.io/compare/jnj-vs-mrk